Publications by authors named "Laura Alwan"

Claim this Profile
N
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022.
Elizabeth A Griffiths, Vivek Roy, Laura Alwan, Kimo Bachiashvili, John Baird

J Natl Compr Canc Netw· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xerostomia: an immunotherapy-related adverse effect in cancer patients.
Hannah Bustillos, Amy Indorf, Laura Alwan, John Thompson, Lindsey Jung

Support Care Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic.
Elizabeth A Griffiths, Laura M Alwan, Kimo Bachiashvili, Anna Brown, Rita Cool

J Natl Compr Canc Netw· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing clinical pharmacist telehealth services during the COVID-19 pandemic.
Eve M Segal, Laura Alwan, Caroline Pitney, Cathy Taketa, Amy Indorf

Am J Health Syst Pharm· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents.
Gary Lau, Laura Alwan, Mary Chi, Michelle Lentz, Katie Hone

J Am Pharm Assoc (2003)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020.
Pamela Sue Becker, Elizabeth A Griffiths, Laura M Alwan, Kimo Bachiashvili, Anna Brown

J Natl Compr Canc Netw· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal toxicity with liposomal doxorubicin in metastatic breast cancer.
Kristyn E Yemm, Laura M Alwan, A Bilal Malik, Lupe G Salazar

J Oncol Pharm Pract· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C infection and chemotherapy toxicity.
Amy Ly, Heather H Cheng, Laura Alwan

J Oncol Pharm Pract· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine proteinuria monitoring for bevacizumab in patients with gynecologic malignancies.
Catherine S Lee, Laura M Alwan, Xiaocui Sun, Katherine A McLean, Renata R Urban

J Oncol Pharm Pract· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collaborative practice model for management of pain in patients with cancer.
Kathryn J Hammer, Eve M Segal, Laura Alwan, Shan Li, Amila M Patel

Am J Health Syst Pharm· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Drug Interaction Between Cabozantinib and Warfarin in a Patient With Renal Cell Carcinoma.
William Travis Foxx-Lupo, Sarah Sing, Laura Alwan, Scott S Tykodi

Clin Genitourin Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma.
Laura M Alwan, Kenneth Grossmann, Daniel Sageser, Joan Van Atta, Neeraj Agarwal

Target Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers.
Minh D Dao, Laura M Alwan, Heidi J Gray, Hisham K Tamimi, Barbara A Goff

Gynecol Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis